Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 13/20 | 0.49 |
| ▸ | PTGS1 | P23219 | 7/20 | 0.49 |
| ▸ | RXRA | P19793 | 2/20 | 0.48 |
| ▸ | NR1H2 | P55055 | 2/20 | 0.48 |
| ▸ | NR1H3 | Q13133 | 2/20 | 0.48 |
| ▸ | PDPK1 | O15530 | 5/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8730016 | 0.91 | PTGS2 (0.56) | PTGS2PTGS1RXRANR1H2NR1H3 | |
| SCHEMBL8733795 | 0.90 | PTGS2 (0.48) | PTGS2PTGS1PDPK1 | |
| SCHEMBL8688570 | 0.90 | PTGS2 (0.58) | PTGS2PTGS1PDPK1 | |
| SCHEMBL8689252 | 0.86 | PTGS2 (0.55) | PTGS2PTGS1PDPK1 | |
| SCHEMBL8637577 | 0.84 | PTGS2 (0.67) | PTGS2PTGS1RXRANR1H2NR1H3 | |
| SCHEMBL6349487 | 0.84 | PTGS2 (0.71) | PTGS2PTGS1PDPK1 | |
| SCHEMBL8688939 | 0.84 | PTGS2 (0.51) | PTGS2PTGS1RXRANR1H2NR1H3 | |
| SCHEMBL8692177 | 0.84 | PTGS2 (0.55) | PTGS2PTGS1RXRANR1H2NR1H3 | |
| SCHEMBL8693453 | 0.83 | PTGS2 (0.47) | PTGS2PTGS1RXRANR1H2NR1H3 | |
| SCHEMBL8732522 | 0.83 | PTGS2 (0.56) | PTGS2PTGS1PDPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5760068-A | NONSTEROIDAL ANTIINFLAMMATORY AGENTS WITH REDUCED SIDE EFFECTS | G.D. SEARLE & CO. (US) | 1998-06-02 | — | — | US | disclosed |
| US-5756529-A | ANTIINFLAMMATORY | G.D. SEARLE & CO. (US) | 1998-05-26 | — | — | US | disclosed |